FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:773-774 September 10, 1998 Number 11 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Flexner, C. PubMed Citation

To the Editor: In his review of inhibitors of human immunodeficiency virus (HIV)–encoded protease (April 30 issue),¹ Dr. Flexner states that ritonavir causes hypertriglyceridemia in no more than 5 percent of patients and has not caused pancreatitis. However, we found that of 52 patients treated with ritonavir for six months, 41 (79 percent) had hypertriglyceridemia (serum triglyceride concentration, >160 mg per deciliter [1.8 mmol per liter]), with values higher than 500 mg per deciliter (5.6 mmol per liter) in 22 patients (42 percent) and higher than 1000 mg per deciliter (11.3 mmol per liter) in 8 (15 percent). The risk . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Chen, D., Misra, A., Garg, A. (2002). Lipodystrophy in Human Immunodeficiency Virus-Infected Patients. J. Clin. Endocrinol. Metab. 87: 4845-4856 [Abstract] [Full Text]